These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 23764522)

  • 1. Human lysozyme inhibits the in vitro aggregation of Aβ peptides, which in vivo are associated with Alzheimer's disease.
    Luo J; Wärmländer SK; Gräslund A; Abrahams JP
    Chem Commun (Camb); 2013 Jul; 49(58):6507-9. PubMed ID: 23764522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural, morphological, and kinetic studies of β-amyloid peptide aggregation on self-assembled monolayers.
    Wang Q; Shah N; Zhao J; Wang C; Zhao C; Liu L; Li L; Zhou F; Zheng J
    Phys Chem Chem Phys; 2011 Sep; 13(33):15200-10. PubMed ID: 21769359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoimmune responses to amyloid structures of Abeta(25-35) peptide and human lysozyme in the serum of patients with progressive Alzheimer's disease.
    Gruden MA; Davudova TB; Malisauskas M; Zamotin VV; Sewell RD; Voskresenskaya NI; Kostanyan IA; Sherstnev VV; Morozova-Roche LA
    Dement Geriatr Cogn Disord; 2004; 18(2):165-71. PubMed ID: 15211072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In situ monitoring Alzheimer's disease β-amyloid aggregation and screening of Aβ inhibitors using a perylene probe.
    Li M; Zhao C; Yang X; Ren J; Xu C; Qu X
    Small; 2013 Jan; 9(1):52-5. PubMed ID: 22976818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biophysical studies of the amyloid β-peptide: interactions with metal ions and small molecules.
    Wärmländer S; Tiiman A; Abelein A; Luo J; Jarvet J; Söderberg KL; Danielsson J; Gräslund A
    Chembiochem; 2013 Sep; 14(14):1692-704. PubMed ID: 23983094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of Mn(II) ion binding to the amyloid-β peptide in Alzheimer's disease.
    Wallin C; Kulkarni YS; Abelein A; Jarvet J; Liao Q; Strodel B; Olsson L; Luo J; Abrahams JP; Sholts SB; Roos PM; Kamerlin SC; Gräslund A; Wärmländer SK
    J Trace Elem Med Biol; 2016 Dec; 38():183-193. PubMed ID: 27085215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphorus dendrimers affect Alzheimer's (Aβ1-28) peptide and MAP-Tau protein aggregation.
    Wasiak T; Ionov M; Nieznanski K; Nieznanska H; Klementieva O; Granell M; Cladera J; Majoral JP; Caminade AM; Klajnert B
    Mol Pharm; 2012 Mar; 9(3):458-69. PubMed ID: 22206488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacterial inclusion bodies of Alzheimer's disease β-amyloid peptides can be employed to study native-like aggregation intermediate states.
    Dasari M; Espargaro A; Sabate R; Lopez del Amo JM; Fink U; Grelle G; Bieschke J; Ventura S; Reif B
    Chembiochem; 2011 Feb; 12(3):407-23. PubMed ID: 21290543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Neuronal Tau Protein Blocks in Vitro Fibrillation of the Amyloid-β (Aβ) Peptide at the Oligomeric Stage.
    Wallin C; Hiruma Y; Wärmländer SKTS; Huvent I; Jarvet J; Abrahams JP; Gräslund A; Lippens G; Luo J
    J Am Chem Soc; 2018 Jul; 140(26):8138-8146. PubMed ID: 29708745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methods for analysis of amyloid-β aggregates.
    Bruggink KA; Müller M; Kuiperij HB; Verbeek MM
    J Alzheimers Dis; 2012; 28(4):735-58. PubMed ID: 22156047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aluminium Binding to Modified Amyloid-β Peptides: Implications for Alzheimer's Disease.
    Mocanu CS; Jureschi M; Drochioiu G
    Molecules; 2020 Oct; 25(19):. PubMed ID: 33022965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid assembly of amyloid-beta peptide at a liquid/liquid interface produces unstable beta-sheet fibers.
    Nichols MR; Moss MA; Reed DK; Hoh JH; Rosenberry TL
    Biochemistry; 2005 Jan; 44(1):165-73. PubMed ID: 15628857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple function fluorescein probe performs metal chelation, disaggregation, and modulation of aggregated Aβ and Aβ-Cu complex.
    Muthuraj B; Layek S; Balaji SN; Trivedi V; Iyer PK
    ACS Chem Neurosci; 2015 Nov; 6(11):1880-91. PubMed ID: 26332658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific binding of a β-cyclodextrin dimer to the amyloid β peptide modulates the peptide aggregation process.
    Wahlström A; Cukalevski R; Danielsson J; Jarvet J; Onagi H; Rebek J; Linse S; Gräslund A
    Biochemistry; 2012 May; 51(21):4280-9. PubMed ID: 22554145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amyloidosis of Alzheimer's Abeta peptides: solid-state nuclear magnetic resonance, electron paramagnetic resonance, transmission electron microscopy, scanning transmission electron microscopy and atomic force microscopy studies.
    Antzutkin ON
    Magn Reson Chem; 2004 Feb; 42(2):231-46. PubMed ID: 14745804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and evaluation of ferrocenoyl pentapeptide (Fc-KLVFF) as an inhibitor of Alzheimer's Aβ₁-₄₂ fibril formation in vitro.
    Wei CW; Peng Y; Zhang L; Huang Q; Cheng M; Liu YN; Li J
    Bioorg Med Chem Lett; 2011 Oct; 21(19):5818-21. PubMed ID: 21855336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alzheimer's disease amyloid β-protein mutations and deletions that define neuronal binding/internalization as early stage nonfibrillar/fibrillar aggregates and late stage fibrils.
    Poduslo JF; Howell KG; Olson NC; Ramirez-Alvarado M; Kandimalla KK
    Biochemistry; 2012 May; 51(19):3993-4003. PubMed ID: 22545812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies of the growth, evolution, and self-aggregation of β-amyloid fibrils using tapping-mode atomic force microscopy.
    Serem WK; Bett CK; Ngunjiri JN; Garno JC
    Microsc Res Tech; 2011 Jul; 74(7):699-708. PubMed ID: 21698718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for Inhibition of Lysozyme Amyloid Fibrillization by Peptide Fragments from Human Lysozyme: A Combined Spectroscopy, Microscopy, and Docking Study.
    Kar RK; Gazova Z; Bednarikova Z; Mroue KH; Ghosh A; Zhang R; Ulicna K; Siebert HC; Nifantiev NE; Bhunia A
    Biomacromolecules; 2016 Jun; 17(6):1998-2009. PubMed ID: 27116396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study of the interaction between the amyloid beta peptide (1-40) and antioxidant compounds by nuclear magnetic resonance spectroscopy.
    Galanakis PA; Bazoti FN; Bergquist J; Markides K; Spyroulias GA; Tsarbopoulos A
    Biopolymers; 2011; 96(3):316-27. PubMed ID: 21053258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.